Stem Cells Market by Stem Cells Type (Adult Stem Cells, Human Embryonic Stem Cells, Induced Pluripotent Stem Cells, Rat Neural Stem Cells), and Applications (Cardiology, Diabetes, Hematology, Neurology, Oncology, and Orthopedics) and Forecast 2017-2021

Stem Cells Market by Stem Cells Type (Adult Stem Cells, Human Embryonic Stem Cells, Induced Pluripotent Stem Cells, Rat Neural Stem Cells), and Applications (Cardiology, Diabetes, Hematology, Neurology, Oncology, and Orthopedics) and Forecast 2017-2021

Stem cell-based therapies, also known as cell replacement therapies or regenerative medicine, provide the means to cure a host of diseases and disorders. There are various types of stem cells (adult stem cells, human embryonic stem cells, induced pluripotent stem cells, rat neural stem cells) available as therapeutic products in different applications (cardiology, diabetes, hematology, neurology, oncology, and orthopedics diseases and disorders). Bone marrow derived stem cells have been used for various therapeutic purposes such as such as thalassemia, aplastic anemia, and sickle cell anemia, and leukemia. Umbilical cord or cord blood is considered a rich source of stem cells which are derived mesenchymal stem cells that are used in regenerative therapies for various medical conditions including diabetes, Alzheimer’s disease, soft tissue repair, etc.

The stem cells market report estimates the market size (Revenue US$ million – 2014 to 2021) and composition of this market based on different stem cell technologies such as stem cells isolation, culture, cryopreservation, IVF, etc., stem cell types (adult stem cells, human embryonic stem cells, induced pluripotent stem cells, rat neural stem cells) available as therapeutic products and different applications (cardiology, diabetes, hematology, neurology, oncology, and orthopedics) available in the global market and also forecasts growth trends (CAGR% – 2017 to 2021).

The global stem cells market report also provides the detailed market landscape, market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global stem cells market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

Major players operating in the global stem cells market and included in this report are Advanced Cell Technology, Inc., Aastrom Biosciences, Inc., BetaStem Therapeutics, Inc., Cardio3 Biosciences, Cellular Dynamics International (CDI), Cynata Therapeutics, Inc., Cytori Therapeutics, Inc., Dendreon Corp., Gamida Cell Ltd., Genea Biocell Pty. Ltd., Lonza Group AG, MaxCyte, Medipost, Mesoblast Ltd., Osiris Therapeutics, Inc., Organovo, Pluristem Therapeutics, Inc., Regeneus Ltd., STEMCELL Technologies, Inc., TerumoBCT, Thermo Fisher Scientific and VIACYTE, Inc.

Category:
  1. Introduction
  2. Executive Summary
    • Market Size Estimation (Revenue US$ Million, 2014-2021)
    • Forecast Estimation (Revenue US$ Million and CAGR%, 2017-2021)
  3. Research Methodology
  4. Market Landscape
    • Market Dynamics
      • Drivers
      • Barriers
      • Opportunities
    • Market Share Analysis
      • Companies
      • Products
    • Market Trends Analysis
      • Key success factors
      • Market Growth Rate
    • Market Attractiveness Analysis
    • Market Profitability Analysis
      • Buyer power
      • Supplier power
      • Barriers to entry
      • Threat of substitute products
      • Rivalry among firms in the industry
    • Distribution Channels
  5. Market Segmentation [refer Market Segments and Companies Tab]
    • Product Type (cells, media, serum, vaccine, protein, instrument, etc.)
    • Source Type
    • Reagents and Consumables Type
    • Diagnostic Test
    • Indication Type
    • Technology
    • Diagnostics, Therapeutic or Surgical Application
    • End User Groups
  6. Geography (Region, Country)
    • North America (U.S., Canada)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Rest of the World (Middle East & Africa)
  7. Company Profiles [refer Market Segments and Companies Tab]
    • Company Overview
    • Financial Snapshot (FY 2014-2016)
    • Product Portfolio
    • Business Strategies
    • Recent Developments
  8. Recommendations
  9. References

Stem Cells Market

1. Product/Stem Cell Type
1.1. Adult/Somatic Stem Cells
1.2. Human Embryonic Stem Cells
1.3. Induced Pluripotent Stem Cells
1.4. Rat Neural Stem Cells
1.5. Other Stem Cells

2. Technology
2.1. Cryopreservation
2.2. Culture
2.3. Expansion and Sub-culture
2.4. In Vitro Fertilization (IVF)
2.5. Isolation

3. Application
3.1. Cardiovascular
3.2. Diabetes
3.3. Hematology
3.4. Incontinence
3.5. Liver disorders
3.6. Myocardial infarction
3.7. Neurology
3.8. Oncology
3.9. Orthopedics
3.10. Spinal cord injuries
3.11. Wound care
3.12. Others

4. Company Profiles
4.1. Advanced Cell Technology
4.2. Angel Biotechnology
4.3. Bioheart
4.4. Biotime Inc.
4.5. Brainstorm Cell Therapeutics
4.6. California Stem Cell Inc.
4.7. Celgene Corporation Inc.
4.8. Cellartis AB
4.9. Cellular Engineering Technologies
4.10. Cytori Therapeutics Inc.
4.11. Osiris Therapeutics
4.12. Stem Cell Technologies Inc.

Request market specific full ToC and sample pages for this report

Full Name*

Email*

Phone Number* [Please add country code]

Subject*

Message*